
Rapid Sterility Testing Market Share
Rapid Sterility Testing Market Research Report Information By Product (Kits & Reagents, Instruments, Services), By Technology (Membrane Filtration, ATP Bioluminescence), By Application (Pharmaceutical and Biological Manufacturing, Medical Device), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Market Summary
As per Market Research Future Analysis, the Global Rapid Sterility Testing Market was valued at USD 2.1 billion in 2022 and is projected to grow from USD 2.27 billion in 2023 to USD 4.26 billion by 2032, with a CAGR of 8.20% during the forecast period. The market is driven by advancements in biotechnology, increasing safety concerns regarding biological products, and the growing demand for sterility tests in pharmaceutical and biopharmaceutical manufacturing. The kits & reagents segment holds the largest market share due to their ease of use and recurring purchases. North America is expected to dominate the market, supported by major players and a growing number of health facilities.
Key Market Trends & Highlights
Key trends driving the Rapid Sterility Testing Market include technological advancements and increasing regulatory standards.
- Market Size in 2022: USD 2.1 billion Projected Market Size by 2032: USD 4.26 billion CAGR from 2023 to 2032: 8.20% North America holds the largest market share due to established healthcare facilities.
Market Size & Forecast
2022 Market Size | USD 2.1 billion |
2023 Market Size | USD 2.27 billion |
2032 Market Size | USD 4.26 billion |
CAGR | 8.20% |
Largest Regional Market | North America. |
Major Players
<p>Key players include Terumo Corporation, Beacon Dickinson, Sanofi, F. Hoffmann-LaRoche, Bayer A.G., Novo Nordisk A.S., Eli Lily and Company, and Merck KGaA.</p>
Market Trends
New emerging technologies are driving the market growth
Along with the advancements in the pharmaceutical and medical fields, the demand for sterility tests will also rise. The biotechnology industry is flourishing; this factor will also boost the growth of the sterility testing market over the forecast period. Safety concerns regarding biological medicinal products are also on the rise. Such factors will boost the sterility testing market in the forthcoming years. New technological developments in sterility testing have made the process more efficient, which will drive market growth.
The membrane filtration sterility testing method is the choice for filterable pharmaceutical products. According to the USP <71>, products are filtered through a 0.45 or 0.2-micron membrane filter in this sterility testing method. The filters are then rinsed with appropriate USP fluid to remove the inhibitors and transferred into fluid thioglycollate medium (FTM) and soybean casein digest medium (SCDM). Both media are incubated for 14 days and checked every day for the presence of microbial growth.
USP<71> Sterility testing suggests the use of fluid thioglycollate medium (FTM) and soybean casein digest medium (SCDM) because of their ability to promote the growth of anaerobic and aerobic microorganisms, respectively. Techniques like these are drivers for market CAGR.
The Pharma market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%. This is accelerated compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, smart medical equipment, and healthcare services. Healthcare as a whole is growing at over 7% year on year. In pharmaceutical and biopharmaceutical industries, sterility testing is carried out at all levels of manufacturing to minimize the risk of product contamination. Subsequently, the growth of this end-use industry in the coming years will considerably boost the overall use of sterility testing.
With stringent regulatory controls, process monitoring, and quality control are carried out for the entire production chain of pharmaceutical and biopharmaceutical products.
In this process, sterility testing is carried out for raw materials, bulk lot release, and final product release testing. In recent years, impressive growth was witnessed in the Pharma and biotech sectors by application; thus, the pharmaceutical and biological manufacturing market has acquired a good market share and is driving the Rapid Sterility Testing market revenue.
<p>The increasing emphasis on rapid sterility testing methods reflects a broader trend towards enhancing quality assurance protocols in the pharmaceutical and biotechnology sectors, thereby ensuring patient safety and compliance with regulatory standards.</p>
U.S. Food and Drug Administration (FDA)
Rapid Sterility Testing Market Market Drivers
Market Growth Projections
The Global Rapid Sterility Testing Market Industry is poised for substantial growth, with projections indicating a market value of 2.45 USD Billion in 2024 and an anticipated increase to 5.4 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 7.44% from 2025 to 2035, reflecting the increasing adoption of rapid sterility testing across various sectors. The market's expansion is likely driven by technological advancements, regulatory compliance, and the rising demand for biopharmaceuticals and medical devices. These factors collectively contribute to a dynamic landscape, positioning rapid sterility testing as a critical component in ensuring product safety and efficacy.
Growth of the Medical Device Industry
The Global Rapid Sterility Testing Market Industry benefits from the growth of the medical device sector. As the demand for innovative medical devices rises, so does the necessity for stringent sterility testing to ensure patient safety. Rapid sterility testing methods are increasingly adopted by medical device manufacturers to comply with regulatory standards and enhance product reliability. The market is projected to reach 5.4 USD Billion by 2035, indicating a robust expansion driven by the need for safe and effective medical devices. This growth underscores the importance of rapid testing solutions in maintaining the integrity of medical products and fostering consumer trust.
Increasing Demand for Biopharmaceuticals
The Global Rapid Sterility Testing Market Industry experiences heightened demand driven by the biopharmaceutical sector. As biopharmaceuticals gain traction, the need for rapid sterility testing becomes paramount to ensure product safety and compliance with regulatory standards. The market is projected to reach 2.45 USD Billion in 2024, reflecting the industry's commitment to maintaining high-quality standards. Regulatory bodies emphasize stringent sterility testing protocols, further propelling the market's growth. This trend indicates a shift towards more efficient testing methods that can provide results in a shorter timeframe, thus enhancing the overall production process in the biopharmaceutical landscape.
Regulatory Compliance and Quality Assurance
Regulatory compliance remains a critical driver for the Global Rapid Sterility Testing Market Industry. Stringent regulations imposed by health authorities necessitate rigorous sterility testing to ensure product safety and efficacy. Companies are compelled to adopt rapid testing methods to meet these regulatory demands efficiently. The increasing focus on quality assurance in manufacturing processes further emphasizes the need for reliable sterility testing solutions. As the industry evolves, adherence to these regulations is likely to shape the market landscape, driving innovation and investment in rapid sterility testing technologies to maintain compliance and uphold product integrity.
Technological Advancements in Testing Methods
Technological innovations significantly influence the Global Rapid Sterility Testing Market Industry. The introduction of advanced testing methodologies, such as molecular techniques and automated systems, enhances the accuracy and speed of sterility testing. These advancements not only reduce the time required for testing but also improve the reliability of results. As a result, manufacturers are increasingly adopting these technologies to streamline their quality control processes. The market is expected to grow at a CAGR of 7.44% from 2025 to 2035, indicating a robust shift towards more sophisticated testing solutions that align with the evolving demands of the biopharmaceutical and medical device sectors.
Rising Incidence of Healthcare-Associated Infections
The Global Rapid Sterility Testing Market Industry is influenced by the rising incidence of healthcare-associated infections (HAIs). These infections pose significant challenges to patient safety and healthcare systems worldwide, prompting healthcare providers to prioritize sterility testing in their protocols. Rapid sterility testing methods enable timely identification of contaminants, thereby reducing the risk of HAIs. The increasing awareness of infection control measures among healthcare professionals further drives the demand for effective testing solutions. As the healthcare sector continues to address these challenges, the market for rapid sterility testing is expected to expand, reflecting a proactive approach to infection prevention.
Market Segment Insights
Rapid Sterility Testing Product Insights
<p>Based on Product, the Rapid Sterility Testing market segmentation includes Kits & Reagents, Instruments, and Services. The kits & reagents segment dominated the market; the large share of this segment can primarily be attributed to ease of use, recurring purchase, and growing preference associated with kits & reagents.</p>
Rapid Sterility Testing Technology Insights
<p>Based on Technology, the Rapid Sterility Testing market segmentation includes membrane filtration and ATP bioluminescence. The membrane filtration segment dominated the market. This is due to the growing demand for liquid formulations and the suitability of such tests with samples containing preservatives and bacteriostatic & fungistatic compounds.</p>
<p>Figure 1 Rapid Sterility Testing Market, by Technology, 2022 & 2032 (USD billion)</p>
<p>Source Secondary Research, Primary Research, MRFR Database, and Analyst Review</p>
Rapid Sterility Testing Application Insights
<p>Based on application, the Rapid Sterility Testing market segmentation includes pharmaceutical and <a href="https://www.marketresearchfuture.com/reports/biologics-market-1339">biological manufacturing</a>, medical devices. The pharmaceutical and biological manufacturing segment dominated the market. This is because the growing demand for the dosage mentioned above forms ly is one of the major factors supporting the market's growth. Furthermore, the rising number of recalls of these dosage forms due to the lack of sterility further supports the demand for sterility testing of pharmaceuticals.</p>
Get more detailed insights about Rapid Sterility Testing Market Research Report-Global Forecast till 2032
Regional Insights
By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American rapid sterility testing market area will dominate this market. Many major market players in this Region are expected to contribute significantly to the market growth. In addition, the growing number of established health clubs and fitness facilities will boost the market growth in this Region.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 Rapid Sterility Testing Market Share By Region 2022 (%)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Rapid Sterility Testing market accounts for the second-largest market share dueincreasing harmonization of the regulatory standards with the ICH standards in developing nations. Moreover, many emerging economies in the Region are undertaking various initiatives to boost the domestic pharmaceutical market and are encouraging multinational companies to set up operations in the Region. Further, the German Rapid Sterility Testing market held the largest market share, and the UK Rapid Sterility Testing market was the fastest-growing market in the European Region.
The Asia-Pacific Rapid Sterility Testing Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to expanding awareness of a healthy lifestyle and nutrition and rising per capita disposable income. Moreover, China’s Rapid Sterility Testing market held the largest market share, and the Indian Rapid Sterility Testing market was the fastest-growing market in the Asia-Pacific region.
Key Players and Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Rapid Sterility Testing market grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. The rapid sterility testing industry must offer cost-effective items to expand and survive in a more competitive and rising market climate.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Rapid Sterility Testing industry to benefit clients and increase the market sector. The Rapid Sterility Testing industry has offered some of the most significant medical advantages in recent years. Major players in the Rapid Sterility Testing market, including Terumo Corporation - Japan Beacon Dickinson - USA Sanofi - USA F.
Hoffmann-LaRoche - Switzerland Bayer A.G. - Germany Novo Nordisk A.S. - USA Eli Lily and Company - USA Owen Mumford LTD - USA Medtronic - USA Greiner Bio-one - USA Abbott laboratories - USA HTL., and others, are attempting to increase market demand by investing in research and development operations.
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and present in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany.Merck KGaA (Switzerland) invested USD 306.5 million in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in various preclinical and clinical laboratory, gene therapy, and cell therapy services for the Pharmaceutical, Medical Device, and Biotechnology industries.Charles River Laboratories, Inc. (US) opened a new High Quality (HQ) Plasmid DNA Centre of Excellence facility at Bruntwood SciTech's Alderley Park in Cheshire, UK. The 16,000 sq. ft facility will provide plasmid DNA manufacturing services.
Key Companies in the Rapid Sterility Testing Market market include






Industry Developments
November 2022 Merck KGaA (Switzerland) invested USD 306.5 million in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
September 2022 Merck KGaA (Switzerland) opened its viral clearance (VC) laboratory as the first phase of the China Biologics Testing Center. This site will operate in China and will conduct viral clearance studies locally across preclinical development to commercialization.
June 2022 Charles River Laboratories, Inc. (US) opened a new High Quality (HQ) Plasmid DNA Centre of Excellence facility at Bruntwood SciTech's Alderley Park in Cheshire, UK. The 16,000 sq. ft facility will provide plasmid DNA manufacturing services.
Future Outlook
Rapid Sterility Testing Market Future Outlook
<p>The Global Rapid Sterility Testing Market is projected to grow at a 8.20% CAGR from 2023 to 2032, driven by technological advancements and increasing regulatory requirements.</p>
New opportunities lie in:
- <p>Invest in automation technologies to enhance testing efficiency and accuracy. Develop rapid testing solutions tailored for emerging biopharmaceuticals. Expand into emerging markets with localized testing solutions to meet regional compliance needs.</p>
<p>By 2035, the market is expected to achieve substantial growth, reflecting evolving industry demands and innovations.</p>
Market Segmentation
Rapid sterility testing Products Outlook
- Kits & Reagents
- Instruments
- Services
Rapid sterility testing Regional Outlook
- {""=>["US"
- "Canada"]}
- {""=>["Germany"
- "France"
- "UK"
- "Italy"
- "Spain"
- "Rest of Europe"]}
- {""=>["China"
- "Japan"
- "India"
- "Australia"
- "South Korea"
- "Rest of Asia-Pacific"]}
- {""=>["Middle East"
- "Africa"
- "Latin America"]}
Rapid sterility testing Technology Outlook
- Membrane Filtration
- ATP Bioluminescence
Rapid sterility testing Application Outlook
- Pharmaceutical and Biological Manufacturing
- Medical Device
Report Scope
Report Attribute/Metric | Details |
Market Size2022 | USD 2.1 billion |
Market Size 2023 | USD 2.27 billion |
Market Size2032 | USD 4.26 billion |
Compound Annual Growth Rate (CAGR) | 8.20% (2023-2032) |
Base Year | 2022 |
Market Forecast Period | 2023-2032 |
Historical Data | 2018- 2022 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Technology, Application, and Region |
Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
Countries Covered | The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Terumo Corporation - Japan Beacon Dickinson - USA Sanofi - USA F. Hoffmann-LaRoche - Switzerland Bayer A.G. - Germany Novo Nordisk A.S. - USA Eli Lily and Company - USA Owen Mumford LTD - USA Medtronic - USA Greiner Bio-one - USA Abbott laboratories - USA HTL |
Key Market Opportunities | Healthcare providers are also able to provide these patients with better healthcare. |
Key Market Dynamics | Two things are driving fast growth in the lancet and pen needles market. |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
How much is the Rapid Sterility Testing market?
The Rapid Sterility Testing market size was valued at USD 2.1 Billion in 2022.
What is the growth rate of the Rapid Sterility Testing market?
The market is projected to grow at a CAGR of 8.20% during the forecast period, 2023-2032.
Which Region held the largest market share in the Rapid Sterility Testing market?
North America had the largest share of the market
Who are the key players in the Rapid Sterility Testing market?
The key players in the market areTerumo Corporation - Japan Beacon Dickinson - USA Sanofi - USA F. Hoffmann-LaRoche - Switzerland Bayer A.G. - Germany Novo Nordisk A.S. - USA Eli Lily and Company - USA Owen Mumford LTD - USA Medtronic - USA Greiner Bio-one - USA Abbott laboratories - USA HTL.
Which Product led the Rapid Sterility Testing market?
The Kits & Reagents Rapid Sterility Testing category dominated the market in 2022.
Which Technology had the largest market share in the Rapid Sterility Testing market?
Membrane Filtration had the largest share of the market.
-
--- "Table of Contents:
-
Chapter 1. Report Prologue
-
Chapter 2. Market Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Chapter 3. Research Methodology
- Introduction
- Primary Research
- Secondary Research
- Market Size Estimation
-
Chapter 4. Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends & Assessment
-
Chapter 5. Market Factor Analysis
-
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
-
Porter’s Five Forces Analysis
-
Chapter 6. Global Rapid Sterility Testing Market, by Product
- Introduction
- Kits & Reagents
-
Market Estimates & Forecast, by Region, 2023-2032
-
Market Estimates & Forecast, by Country, 2023-2032
- Instruments
- Services
-
Chapter 7. Global Rapid Sterility Testing Market, by Technology
- Introduction
- ATP bioluminescence
- Membrane Filtration
- Others
-
Chapter 8. Global Rapid Sterility Testing Market, by Application
- Introduction
- Pharmaceutical and Biological Manufacturing
- Medical Device Manufacturing
- Other Application
-
Chapter 9. Global Rapid Sterility Testing Market, by Region
- Introduction
-
Americas
- North America
- South America
-
Europe
- Western Europe
- Eastern Europe
-
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
-
Middle East & Africa
- Middle East
- Africa
-
Chapter 10. Company Landscape
- Introduction
- Market Share Analysis
- Key Development & Strategies
-
Chapter 11. Company Profiles
-
Charles River Laboratories, Inc
- Company Overview
- Product Overview
- Financials Overview
- Key Developments
- SWOT Analysis
-
Merck KGaA
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Rapid Micro Biosystems, In
- Company Overview
- Product Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
BioMérieux
- Company Overview
- Product Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
Eurofins Scientific
- Company Overview
- Product Overview
- Financial overview
- Key Developments
- SWOT Analysis
-
Becton, Dickinson and Company
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Sartorius AG
- Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Thermo Fisher Scientific
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Gibraltar Laboratories
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
FOCUS Laboratories
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
- Others
-
Charles River Laboratories, Inc
-
Chapter 12. MRFR Conclusion
-
Key Findings
- From CEO’s Viewpoint
- Unmet Needs of the Market
- Key Companies to Watch
- Predictions for the Rapid Sterility Testing Industry
-
Key Findings
-
Chapter 13. Appendix
-
List of Tables and Figures
- LIST OF TABLES
- Table 1 Global Rapid Sterility Testing Market Synopsis, 2023-2032
- Table 2 Global Rapid Sterility Testing Market Estimates and Forecast, 2023-2032 (USD Million)
- Table 3 Global Rapid Sterility Testing Market, by Region, 2023-2032 (USD Million)
- Table 4 Global Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 5 Global Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 7 Global Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 8 North America: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 9 North America: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 10 North America: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 11 US: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 12 US: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 13 US: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 14 Canada: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 15 Canada: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 16 Canada: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 17 South America: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 18 South America: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 19 South America: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 20 Europe: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 21 Europe: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 22 Europe: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 23 Western Europe: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 24 Western Europe: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 25 Western Europe: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 26 Eastern Europe: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 27 Eastern Europe: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 28 Eastern Europe: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 29 Asia-Pacific: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 30 Asia-Pacific: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 31 Asia-Pacific: Rapid Sterility Testing Market, by Application, 2023-2032 (USD Million)
- Table 32 Middle East & Africa: Rapid Sterility Testing Market, by Product, 2023-2032 (USD Million)
- Table 33 Middle East & Africa: Rapid Sterility Testing Market, by Technology, 2023-2032 (USD Million)
- Table 34 Middle East & Africa: Rapid Sterility Testing Market, by Application, 2018– 2023 (USD Million) LIST OF FIGURES
- Figure 1 Research Process
- Figure 2 Segmentation for the Global Rapid Sterility Testing Market
- Figure 3 Segmentation Market Dynamics for Global Rapid Sterility Testing Market
- Figure 4 Global Rapid Sterility Testing Market Share, by Product, 2022
- Figure 5 Global Rapid Sterility Testing Market Share, by Technology, 2022
- Figure 6 Global Rapid Sterility Testing Market Share, by Application, 2022
- Figure 7 Global Rapid Sterility Testing Market Share, by Region, 2022
- Figure 8 North America: Rapid Sterility Testing Market Share, by Country, 2022
- Figure 9 Europe: Rapid Sterility Testing Market Share, by Country, 2022
- Figure 10 Asia-Pacific: Rapid Sterility Testing Market Share, by Country, 2022
- Figure 11 Middle East & Africa: Rapid Sterility Testing Market Share, by Country, 2022
- Figure 12 Global Rapid Sterility Testing Market: Company Share Analysis, 2022 (%)
- Figure 13 Charles River Laboratories, Inc: Key Financials
- Figure 14 Charles River Laboratories, Inc: Segmental Revenue
- Figure 15 Charles River Laboratories, Inc: Geographical Revenue
- Figure 16 Merck KGaA: Key Financials
- Figure 17 Merck KGaA: Segmental Revenue
- Figure 18 Merck KGaA: Geographical Revenue
- Figure 19 Rapid Micro Biosystems, In: Key Financials
- Figure 20 Rapid Micro Biosystems, In: Segmental Revenue
- Figure 21 Rapid Micro Biosystems, In: Geographical Revenue
- Figure 22 BioMérieux: Key Financials
- Figure 23 BioMérieux: Segmental Revenue
- Figure 24 BioMérieux: Geographical Revenue
- Figure 25 Eurofins Scientific: Key Financials
- Figure 26 Eurofins Scientific: Segmental Revenue
- Figure 27 Eurofins Scientific. Geographical Revenue
- Figure 28 Becton, Dickinson and Company: Key Financials
- Figure 29 Becton, Dickinson and Company: Segmental Revenue
- Figure 30 Becton, Dickinson and Company: Geographical Revenue
- Figure 31 Sartorius AG: Key Financials
- Figure 32 Sartorius AG: Segmental Revenue
- Figure 33 Sartorius AG: Geographical Revenue
- Figure 34 Thermo Fisher Scientific: Key Financials
- Figure 35 Thermo Fisher Scientific: Segmental Revenue
- Figure 36 Thermo Fisher Scientific: Geographical Revenue
- Figure 37 Gibraltar Laboratories: Key Financials
- Figure 38 Gibraltar Laboratories: Segmental Revenue
- Figure 39 Gibraltar Laboratories: Geographical Revenue
- Figure 40 FOCUS Laboratories : Key Financials
- Figure 41 FOCUS Laboratories: Segmental Revenue
- Figure 42 FOCUS Laboratories: Geographical Revenue"
Rapid Sterility Testing Market Segmentation
Rapid Sterility Testing Product Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Services
Rapid Sterility Testing Technology Outlook (USD Billion, 2018-2032)
Membrane Filtration
ATP Bioluminescence
Rapid Sterility Testing Application Outlook (USD Billion, 2018-2032)
Pharmaceutical and Biological Manufacturing
Medical Device
Rapid Sterility Testing Regional Outlook (USD Billion, 2018-2032)
North AmericaOutlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
North America Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
North America Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
US Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
US Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
US Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
CANADA Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
CANADA Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
CANADA Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Europe Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Europe Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Europe Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Germany Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Germany Rapid Sterility Testing Technology
Membrane Filtration
ATP Bioluminescence
Germany Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
France Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
France Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
France Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
UK Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
UK Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
UK Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
ITALY Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
ITALY Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
ITALY Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
SPAIN Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Spain Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Spain Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Rest Of Europe Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
REST OF EUROPE Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
REST OF EUROPE Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Asia-Pacific Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Asia-Pacific Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Asia-Pacific Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
China Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
China Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
China Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Japan Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Japan Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Japan Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
India Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
India Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
India Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Australia Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Australia Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Australia Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Rest of Asia-Pacific Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Rest of Asia-Pacific Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Rest of the World Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Rest of the World Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Rest of the World Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Middle East Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Middle East Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Middle East Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Africa Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Africa Rapid Sterility Testing by TechnologyMembrane Filtration
Autoimmune Product
Africa Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device
Latin America Outlook (USD Billion, 2018-2032)
Kits & Reagents
Instruments
Latin America Rapid Sterility Testing by TechnologyMembrane Filtration
ATP Bioluminescence
Latin America Rapid Sterility Testing by ApplicationPharmaceutical and Biological Manufacturing
Medical Device

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment